14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.700 Thursday, 2nd May 2024 ADXS stock ended at $0.531. This is 17.51% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 17.53% from a day low at $0.519 to a day high of $0.610.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Nov 04, 2021 $0.512 $0.512 $0.490 $0.500 4 358 402
Nov 03, 2021 $0.510 $0.524 $0.502 $0.505 3 287 133
Nov 02, 2021 $0.502 $0.540 $0.500 $0.510 8 412 337
Nov 01, 2021 $0.488 $0.509 $0.485 $0.507 5 980 256
Oct 29, 2021 $0.480 $0.505 $0.475 $0.485 8 221 021
Oct 28, 2021 $0.487 $0.500 $0.469 $0.484 4 982 903
Oct 27, 2021 $0.500 $0.529 $0.488 $0.490 7 424 371
Oct 26, 2021 $0.480 $0.512 $0.476 $0.494 7 946 205
Oct 25, 2021 $0.467 $0.523 $0.467 $0.486 11 830 839
Oct 22, 2021 $0.490 $0.499 $0.451 $0.468 5 945 161
Oct 21, 2021 $0.517 $0.523 $0.500 $0.504 2 808 554
Oct 20, 2021 $0.510 $0.535 $0.500 $0.515 5 176 729
Oct 19, 2021 $0.488 $0.528 $0.480 $0.508 7 135 747
Oct 18, 2021 $0.470 $0.504 $0.470 $0.487 4 637 991
Oct 15, 2021 $0.490 $0.496 $0.470 $0.472 2 955 160
Oct 14, 2021 $0.522 $0.530 $0.475 $0.486 4 361 105
Oct 13, 2021 $0.505 $0.560 $0.500 $0.524 9 390 193
Oct 12, 2021 $0.480 $0.518 $0.475 $0.510 5 050 813
Oct 11, 2021 $0.490 $0.520 $0.481 $0.481 3 930 454
Oct 08, 2021 $0.471 $0.535 $0.450 $0.499 12 800 171
Oct 07, 2021 $0.456 $0.490 $0.455 $0.470 2 381 402
Oct 06, 2021 $0.450 $0.470 $0.450 $0.453 2 381 798
Oct 05, 2021 $0.490 $0.500 $0.444 $0.459 6 883 146
Oct 04, 2021 $0.502 $0.511 $0.491 $0.497 2 349 194
Oct 01, 2021 $0.530 $0.531 $0.501 $0.510 5 136 391
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT